Loading clinical trials...
Loading clinical trials...
This observational study is conducted globally. The aim of the study is to investigate the effectiveness and safety of real-life treatment with Norditropin®. The study population will consist of child...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novo Nordisk A/S
NCT06109935 · Growth Hormone Deficiency in Children
NCT05230550 · Adult Growth Hormone Deficiency
NCT04970654 · Growth Hormone Deficiency in Children
NCT07259564 · Adult Growth Hormone Deficiency (AGHD)
NCT01909479 · Adult Growth Hormone Deficiency
Novo Nordisk Investigational Site
Prov. de Buenos Aires
Novo Nordisk Investigational Site
Brussels
Novo Nordisk Investigational Site
Prague
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions